EBV infection raises the possibility of immunotherapy, as EBV proteins, such as latent membrane proteins (LMP1, LMP2) and EBV nuclear antigen-1, can elicit a virus-specific immune response. This evidence concerns the gene PSMB9 and Epstein-Barr virus infection.